Anqi Lin
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Oncology 61
- Cancer Immunotherapy and Biomarkers 40
- Lung Cancer Research Studies 11
- CAR-T cell therapy research 8
-
- Epigenetics and DNA Methylation 9
- Co-authors
- Peng Luo (103 shared papers)Jian Zhang (83 shared papers)Quan Cheng (37 shared papers)Ting Wei (18 shared papers)Zaoqu Liu (23 shared papers)Aimin Jiang (24 shared papers)Hui Meng (4 shared papers)Zaoqu Liu (15 shared papers)
- Journals
- Frontiers in Immunology (6 papers)International Journal of Surgery (5 papers)Journal of Clinical Oncology (5 papers)Molecular Cancer (4 papers)Journal of Translational Medicine (4 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Anqi Lin
140 papers receiving 2.8k citations
Anqi Lin's Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 910
- Immunology 468
- Health Informatics 29
- Cancer Research 291
- Pulmonary and Respiratory Medicine 452
Countries citing papers authored by Anqi Lin
This map shows the geographic impact of Anqi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Lin more than expected).
Fields of papers citing papers by Anqi Lin
This network shows the impact of papers produced by Anqi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Lin. The network helps show where Anqi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anqi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer Hit paper breakdown → | 2020 | 257 |
| 2 | 2019 | 175 | |
| 3 | Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database Hit paper breakdown → | 2023 | 128 |
| 4 | 2023 | 98 | |
| 5 | 2021 | 94 | |
| 6 | 2022 | 94 | |
| 7 | 2021 | 76 | |
| 8 | CTLs heterogeneity and plasticity: implications for cancer immunotherapy Hit paper breakdown → | 2024 | 74 |
| 9 | 2020 | 69 | |
| 10 | 2023 | 69 | |
| 11 | 2024 | 63 | |
| 12 | 2020 | 61 | |
| 13 | 2022 | 53 | |
| 14 | 2022 | 51 | |
| 15 | 2024 | 49 | |
| 16 | 2022 | 46 | |
| 17 | 2019 | 45 | |
| 18 | From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy Hit paper breakdown → | 2025 | 44 |
| 19 | 2020 | 42 | |
| 20 | 2020 | 41 |
About Anqi Lin
Anqi Lin is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Surgery, having authored 154 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (40 papers), Ferroptosis and cancer prognosis (16 papers), Lung Cancer Research Studies (11 papers), Immune Cell Function and Interaction (11 papers), Epigenetics and DNA Methylation (9 papers), Lung Cancer Treatments and Mutations (9 papers), Bladder and Urothelial Cancer Treatments (8 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Oncology (910 citations), Immunology (468 citations), Health Informatics (29 citations), Cancer Research (291 citations) and Pulmonary and Respiratory Medicine (452 citations). Anqi Lin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Peng Luo, Jian Zhang, Quan Cheng, Ting Wei, Zaoqu Liu, Aimin Jiang, Hui Meng, Zaoqu Liu, Chaozheng Zhou and Aimin Jiang. Their work appears in journals such as Frontiers in Immunology, International Journal of Surgery, Journal of Clinical Oncology, Molecular Cancer and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.